Sort by
Keyphrases
Staphylococcus Aureus
57%
Clostridium Difficile Infection
46%
β-lactamase Inhibitor
46%
β-lactamase
39%
In Vivo Activity
36%
Vancomycin
34%
Aminomethyl
33%
In Vitro Activity
29%
Penem
28%
Methylidene
28%
Structure-activity Relationship
27%
Mannopeptimycin
26%
Pseudomonas Aeruginosa (P. aeruginosa)
25%
Rabbit Model
25%
Antibiotics
23%
Lantibiotics
22%
Glycylcycline
22%
Imipenem
21%
Glycopeptides
21%
In Vivo Efficacy
20%
Carbapenems
19%
Hamster
19%
Pneumonia
18%
Meropenem
18%
Antibacterial Activity
18%
Difficile
18%
Antimicrobial Activity
18%
Murine Model
18%
Prodrug
17%
Alpha-toxin
16%
Preclinical Development
16%
Piperacillin
15%
Infection Model
15%
Escherichia Coli
15%
Methicillin-resistant S. Aureus
14%
Metallo-β-lactamase
14%
Gram-negative Bacteria
14%
Oral Function
14%
Lung
13%
β-lactam Antibiotics
13%
Klebsiella Pneumoniae (K. pneumoniae)
13%
Hamster Model
13%
Imidazole
12%
Streptococcus Pneumoniae
12%
Pathogen-specific
12%
In Vitro Antibacterial Activity
12%
Immunoglobulin
12%
Specific Immunoglobulins
12%
Experimental Infection Model
11%
Semi-synthetic
11%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
76%
Staphylococcus Aureus
69%
Penicillinase
59%
Clostridium Difficile Infection
37%
Antibacterial Activity
35%
Antiinfective Agent
32%
Structure Activity Relationship
32%
Vancomycin
30%
Meticillin
29%
Antimicrobial Agent
28%
Glycopeptide
24%
Carbapenem
24%
Antibiotics
24%
Lantibiotic
22%
Pseudomonas aeruginosa
21%
Escherichia coli
20%
Rabbit Model
19%
Infectious Agent
19%
Drug Development
17%
Imipenem
17%
Glycylcycline Derivative
16%
Alpha Toxin
16%
Serine
16%
Piperacillin
14%
Prodrug
14%
Klebsiella pneumoniae
12%
Enterobacteriaceae
12%
Carbapenemase
12%
Imidazole
12%
Carbapenem Derivative
12%
Bacterial Infection
11%
Gram Negative Bacterium
11%
Linezolid
11%
Experimental Infection
11%
Thiazepine
11%
Tigecycline
11%
Polypeptide Antibiotic Agent
11%
Messenger RNA
11%
Antibiotic Agent
11%
Staphylococcal Infection
11%
Streptococcus Pneumonia
11%
Vancomycin-Resistant Enterococcus
10%
Pharmacokinetics
10%
Meropenem
10%
Hamster Model
10%
Leporidae
9%
Diseases
9%
Pseudomonas
9%
Peptoclostridium difficile
9%
Tobramycin
9%
Immunology and Microbiology
Infection
100%
Staphylococcus Aureus
44%
In Vitro
29%
Minimum Inhibitory Concentration
23%
Infectious Agent
22%
Peptoclostridium difficile
22%
Klebsiella pneumoniae
16%
Hamster Model
15%
Immunoglobulin A
14%
Antimicrobial Agent
11%
Glycopeptide
11%
Human Respiratory Syncytial Virus
11%
Secretion (Process)
11%
Lantibiotic
11%
Mouse Model
11%
Gene Expression
11%
Pharmacokinetics
9%
Colony-Forming Unit
9%
Colony Forming Unit S
9%
Methicillin-Resistant Staphylococcus Aureus
8%
Enterobacteriaceae
8%
Antibacterial Activity
8%
Pyelonephritis
8%
Body Weight
8%
Endocarditis
8%
Fatty Acid Synthesis
7%
Blood Plasma
7%
Pseudomonas
7%
Escherichia coli
7%
Neutralization
7%
Monoclonal Antibody
7%
Chlorocebus Aethiops
7%
Gram-Negative Bacteria
6%
Rabbit Model
6%
Antitoxin
6%
Antimicrobial Activity
6%
Titer
5%
Wild Type
5%
Immunopotentiation
5%
Mupirocin
5%
Pseudomonas aeruginosa
5%
Serine
5%
Rat Model
5%
Acinetobacter Baumannii
5%
Precursor
5%
Enterobacterales
5%
Pharmacodynamics
5%
Secretory Immunoglobulin
5%
MIC90
5%
Lymph Node
5%
